4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001793412-26-000008
CHIEF FINANCIAL OFFICER sold 102,817 shares at an average $4.72 ($485,042)
From the SEC's structured data for this filing
Trades in this filing
Alam Kamran · CHIEF FINANCIAL OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-23 | Sale : show line 1 in the form | −78,968 | $4.75 | $375,098 | 1,467,635 | D |
| 2026-01-26 | Sale : show line 2 in the form | −23,849 | $4.61 | $109,944 | 1,443,786 | D |
| Open-market sales · 102,817 sh · avg $4.72 · $485,042 | ||||||
Loading xslF345X05/form4-01272026_040101.xml…